Logan Capital Management Inc Amgen Inc Transaction History

Logan Capital Management Inc

$2.34 Billion
Q3 2024

A detailed history of Logan Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Logan Capital Management Inc holds 26,709 shares of AMGN stock, worth $7.3 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

26,709

Previous 28,042 4.75%

Holding current value

$7.3 Million

Previous $8.76 Million 1.78%

% of portfolio

0.37%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 06, 2024	SELL	$309.38 - $337.38 $412,403 - $449,727	-1,333 Reduced 4.75%	26,709 $8.61 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $240,153 - $291,849	-914 Reduced 3.16%	28,042 $8.76 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $28,500 - $34,403	106 Added 0.37%	28,956 $8.23 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $452,077 - $509,997	-1,768 Reduced 5.77%	28,850 $8.31 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $378,701 - $470,168	-1,732 Reduced 5.35%	30,618 $8.23 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $370,687 - $438,330	-1,730 Reduced 5.08%	32,350 $7.18 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $7.59 Million - $9.26 Million	-33,632 Reduced 49.67%	34,080 $8.24 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $15,803 - $20,079	-69 Reduced 0.1%	67,712 $17.8 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $37,709 - $42,529	-168 Reduced 0.25%	67,781 $15.3 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $1.49 Million - $1.65 Million	-6,437 Reduced 8.65%	67,949 $16.5 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.72 Million - $1.9 Million	7,838 Added 11.78%	74,386 $18 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $568,399 - $650,480	-2,858 Reduced 4.12%	66,548 $15 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.26 Million - $1.47 Million	5,917 Added 9.32%	69,406 $14.8 Million
Q2 2021 Aug 17, 2021	BUY	$233.58 - $259.14 $196,207 - $217,677	840 Added 1.34%	63,489 $15.5 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $216,806 - $252,652	977 Added 1.58%	62,649 $15.6 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.01 Million - $1.2 Million	4,675 Added 8.2%	61,672 $14.2 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2.07 Million - $2.3 Million	-8,805 Reduced 13.38%	56,997 $14.5 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $1.75 Million - $2.15 Million	8,862 Added 15.56%	65,802 $15.5 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1.61 Million - $2.14 Million	-8,839 Reduced 13.44%	56,940 $11.5 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1.04 Million - $1.34 Million	-5,502 Reduced 7.72%	65,779 $15.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $434,752 - $520,924	2,497 Added 3.63%	71,281 $13.8 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $1.47 Million - $1.72 Million	8,794 Added 14.66%	68,784 $12.7 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $3.2 Million - $3.6 Million	17,669 Added 41.75%	59,990 $11.4 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1 Million - $1.17 Million	-5,623 Reduced 11.73%	42,321 $8.24 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $85,048 - $95,880	459 Added 0.97%	47,944 $9.94 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $299,388 - $336,277	1,803 Added 3.95%	47,485 $8.77 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $7.47 Million - $8.73 Million	44,115 Added 2815.25%	45,682 $7.79 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $506 - $565	-3 Reduced 0.19%	1,567 $273,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $41,822 - $47,750	250 Added 18.94%	1,570 $293,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,320	1,320 $227,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Amgen Inc Transaction History